首页> 外文期刊>Journal of liquid chromatography and related technologies >In-vitro drug-drug interaction studies of diltiazem with floroquinolones
【24h】

In-vitro drug-drug interaction studies of diltiazem with floroquinolones

机译:用氟喹诺酮类药物的体外药物 - 药物相互作用研究

获取原文
获取原文并翻译 | 示例
           

摘要

Diltiazem is an established cardiovascular drug mainly used for the management of hypertension specifically for the angina pectoris. Fluoroquinolones are widely prescribed against the treatment of severe infections. In vitro relations of diltiazem with fluoroquinolones (ciprofloxacin, levofloxacin, norfloxacin, and ofloxacin) were examined using spectrophotometric and separation techniques, i.e., RP-HPLC. Diltiazem's availabilities were observed to be predisposed highly in the presence of fluoroquinolones. To investigate the mechanism of interaction in a variety of dissolution environments, i.e., simulating body environments with regard to pH on these interactions has been studied. Moreover, complex of diltiazem-fluoroquinolones were prepared and elucidated through IR spectroscopy and confirmed by computational molecular modeling.
机译:Diltiazem是一种既定的心血管药物,主要用于管理高血压的管理,专门用于心绞痛。 氟代喹啉酮被广泛规定对治疗严重感染的治疗。 使用分光光度法和分离技术研究Diltiazem与氟喹诺酮类(环丙沙星,左氧氟沙星,诺氟沙星和氧氟沙星)的体外关系,即RP-HPLC。 观察到Diltiazem的可用性在氟代喹啉的存在下高度倾向于。 为了研究各种溶出环境中的相互作用机理,即,已经研究了在这些相互作用上的对pH进行的模拟身体环境。 此外,通过IR光谱法制利地制备了Diltiazem-Fluoroquinolones的复合物,并通过计算分子建模证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号